Don’t miss the latest developments in business and finance.

Unichem Laboratories receives USFDA approval for Apremilast Tablets

Bs_logoImage
Capital Market
Last Updated : Feb 19 2021 | 12:04 PM IST
Unichem Laboratories has received ANDA approval for its Apremilast Tablets, 10 mg, 20 mg and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Amgen's Otezla (apremilast) Tablets, 10 mg, 20 mg, and 30 mg.

Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Feb 19 2021 | 11:55 AM IST

Next Story